Colgate-Palmolive India Reports 4.3% Rise in Q2 Net Profit to ₹341.6 Crore

FMCG major and oral care products maker Colgate-Palmolive India Ltd (CPIL) reported a 4.3 per cent increase in net profit at ₹341.57 crore for the September quarter, helped by volume gains and pricing actions.

The company had posted a net profit of ₹327.51 crore in the corresponding July-September quarter a year ago, according to a regulatory filing.

CPIL's sales during the quarter were up 12.22 per cent to ₹1,691.57 crore, compared to ₹1,507.24 crore in the same period a year ago. Total expenses for the second quarter of the current fiscal year rose 16 per cent to ₹1,267.28 crore.

The company's total income, including other income, stood at ₹1,727.50 crore, marking a 12.57 per cent increase in the September quarter. For the first half (H1) of the fiscal year, CPIL's total income reached ₹3,353.60 crore, up 12.3 per cent.

Commenting on the results, Managing Director and CEO Manish Anandani noted that this marks the second consecutive quarter of double-digit topline growth for CPIL, reflecting broad-based growth momentum across its brands and distribution channels.

"The toothpaste portfolio delivered high-single digit volume expansion, led by our premium toothpaste range and strong performance in Colgate MaxFresh," Anandani said.

CPIL's gross margin expanded by 40 basis points year-on-year to 69.6 per cent in the second quarter, driven by a consistent focus on the Funding the Growth program. The company stated it remains committed to navigating commodity cost fluctuations through disciplined cost savings and calibrated pricing actions, alongside increased investments in brand building and premiumisation.

Additionally, CPIL's board, during its meeting, declared a first interim dividend of ₹24 per equity share, with a face value of Re 1 each.

On the market front, shares of Colgate-Palmolive India Ltd settled at ₹1,685 on the BSE, down 2.32 per cent following the announcement.

"Colgate-Palmolive India's steady performance highlights the resilience of established FMCG players in managing commodity cost fluctuations through disciplined cost savings and calibrated pricing. Achieving consecutive quarters of double-digit topline growth, alongside margin expansion, demonstrates that strong brand equity and targeted premiumisation continue to drive consumer demand in the oral care segment." — Dr. Shishir Gupta, Founder & CEO, StartupLanes